Stay connected and up-to-date on the latest news and reports. It’s never been easier to know what’s going on in digital health.
2024 has been off to a great start at HealthXL, with topics ranging from Tech Enabled Change in Oncology Workflows to a Masterclass: The Legacy of Pear Therapeutics
Read moreIntroducing new technologies into healthcare settings can be challenging. For example, outdated systems, such as paper-based processes for imaging, can hinder the adoption of new digital health solutions. The medical field can improve treatment and care by deploying new technologies. Additionally e
Read moreIt's been another month of great events at HealthXL, with topics ranging from Pharma 3.0 and how to do digital health better, to the role medical affairs in the age of digitalisation. Here are my top six takeaways from HealthXL meetings that took place over the past two months.
Read moreFew would argue that medical affairs plays a strategic role for digital health in pharma, despite their strategic positioning between commercial and R&D. This new report reevaluates the role of medical affairs in pharma and asks what may be holding them back from a greater role in digital health.
Read moreThe HealthXL team has returned to Dublin from Gothenburg following yet another successful Global Gathering, this time in collaboration with AstraZeneca. The resounding consensus on the day was that tech in clinical trials will work.
Read moreIt's been another month of great events at HealthXL, with topics ranging from ‘DTx Reimbursement: Navigating Medicare & Medicaid Coverage’ to ‘Quantifying the Benefits of Digital Biomarkers in Pharma’.
Read moreIn recent years, medical affairs has slowly been brought into the digital era with the introduction of tracking tools and new virtual channels for communication with health care practitioners HCPs. Patients' needs and expectations are also changing rapidly.
Read moreWith marketing leaders from across leading pharma organisations, Steve Peretz, Healthcare Practice Lead, Digital Products, Appnovation and Angela Rosales, Group Director, Strategy, Appnovation, led the session to share key insights into evolving product approaches with an ecosystem strategy, empower
Read moreThis month, experts from the HealthXL community led meetings on topics ranging from accounting for cultural differences in digital mental health services to reducing financial toxicity in oncology. In this article, Tess gives her top five meeting takeaways from July.
Read moreDigital technology is poised to change healthcare. In this webinar, the panel explored key challenges that lie ahead for this specialty and developments they anticipate to take place over the next 10-15 years as we collectively navigate a path towards a unified, digitally enabled healthcare system.
Read moreIn a recent masterclass, the discussion revolved around approaches, scalability, and accessibility of digital health solutions in GLP-1 medication and obesity management. In this article, we highlight the key insights shared during the session.
Read moreIntroducing new technologies into healthcare settings can be challenging. For example, outdated systems, such as paper-based processes for imaging, can hinder the adoption of new digital health solutions. The medical field can improve treatment and care by deploying new technologies. Additionally e
Read moreIt's been another month of great events at HealthXL, with topics ranging from Pharma 3.0 and how to do digital health better, to the role medical affairs in the age of digitalisation. Here are my top six takeaways from HealthXL meetings that took place over the past two months.
Read moreFew would argue that medical affairs plays a strategic role for digital health in pharma, despite their strategic positioning between commercial and R&D. This new report reevaluates the role of medical affairs in pharma and asks what may be holding them back from a greater role in digital health.
Read moreThe HealthXL team has returned to Dublin from Gothenburg following yet another successful Global Gathering, this time in collaboration with AstraZeneca. The resounding consensus on the day was that tech in clinical trials will work.
Read moreIt's been another month of great events at HealthXL, with topics ranging from ‘DTx Reimbursement: Navigating Medicare & Medicaid Coverage’ to ‘Quantifying the Benefits of Digital Biomarkers in Pharma’.
Read moreIn recent years, medical affairs has slowly been brought into the digital era with the introduction of tracking tools and new virtual channels for communication with health care practitioners HCPs. Patients' needs and expectations are also changing rapidly.
Read moreWith marketing leaders from across leading pharma organisations, Steve Peretz, Healthcare Practice Lead, Digital Products, Appnovation and Angela Rosales, Group Director, Strategy, Appnovation, led the session to share key insights into evolving product approaches with an ecosystem strategy, empower
Read more